AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Sanofi Consumer Healthcare India Limited Files SEBI Regulation 74(5) Certificate for Q3 FY26
Sanofi Consumer Healthcare India Limited
January 13, 2026, 10:28 AM
Top Queries to Ask About Sanofi Consumer Healthcare India Limited
InstantThinking to buy or sell Sanofi Consumer Healthcare India Limited? Ask AI before you act.
Trusted by 5,000+ users
More Details on This News
Sanofi Consumer Healthcare India Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025.
The company received the confirmation from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), on January 1, 2026. The certificate confirms that securities received from depository participants for dematerialization during the specified quarter were processed and listed on the stock exchanges. It also states that the security certificates were mutilated and cancelled, with the depositories' names substituted in the register of members within the prescribed timelines.
The filing was made to the BSE Limited and the National Stock Exchange of India Limited on January 13, 2026.
More News on Sanofi Consumer Healthcare India Limited
Analyze Sanofi Consumer Healthcare India Limited